Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.22.1
Accrued Expenses
3 Months Ended
Mar. 31, 2022
Accrued Expenses [Abstract]  
ACCRUED EXPENSES

8 — ACCRUED EXPENSES

 

Accrued expenses consist of the following:

 

    March 31, 2022     December 31,
2021
 
Clinical research organization services and expenses   $ 995,088     $ 1,826,479  
Employee compensation     357,535       520,795  
Preclinical and manufacturing expenses     293,150      
 
Legal and consulting services     39,058       29,656  
Minimum license royalties     10,000      
 
Total accrued expenses   $ 1,694,831     $ 2,376,930